Home / Resources / Articles / Islet Transplantation Faces Serious Challenges

Islet Transplantation Faces Serious Challenges

Oct 12, 2004

Very few patients remain insulin independent beyond 4 years after transplantation. Islet transplantation represents a most impressive recent advance in the search for a type 1 diabetes mellitus cure. While several hundred patients have achieved at least temporary insulin independence after receiving the islet "mini-organs" (containing insulin-producing ß cells), very few patients remain insulin independent beyond 4 years after transplantation.

Worldwide, more than 750 individuals with type 1 diabetes mellitus have received allogeneic islet transplants since 1974, in an effort to cure their chronic condition. Though this is still a small number, much has been learned, especially since the promising results of the Edmonton group were published in 2000


The initial enthusiasm over the observation that islet transplantation can restore insulin-independent euglycemia to patients with long-standing T1DM has been dampened by complications associated with the procedure itself and the immunosuppression necessary to prevent rejection of the transplanted islets, as well as by the gradual loss of islet function and other problems arising from the placement of allogeneic islets in the liver

J. Clin. Invest. 114:877-883 (2004).


Professional CE
Pharmacists learn how you can help patients with hyperlipidemia we now have 2, 1 hour ACPE approved credits for you. Please visit Defining the Role of the Pharmacist in Cholesterol Monitoring http://ce.rxschool.com/cholesterol_monitoring.cfm and The Role of Cholesterol and Hyperlipidemia in the Pathophysiology of Cardiovascular Disease